Nutex Health, Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clinigence Holdings, Inc. (CLNH)
CIK: 0001479681
Period of Report: 2021-01-28

Reporting Person: Waters John J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-28	Director Stock Option (right to buy)	$1.61	A	45000	Acquired	2028-01-28	Common Stock (45000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	31746	Direct

Footnotes

F1: Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger.